← Back to headlines
Dr Reddy's shares fall due to semaglutide supply issues
India's Dr Reddy's Laboratories is experiencing its worst trading day in three years following disruptions in the supply of semaglutide.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Otedola Increases First HoldCo Stake with N20.7 Billion Share Purchase
16m ago
Alphabet Launches Inaugural Australian Dollar Bond Sale for AI Investment
1h ago
Paramount Demands $1.88 Billion Bond in Merger Lawsuit
1h ago
German government open to selling Commerzbank stake to UniCredit under conditions
2h ago